ICD-10-CM Codes
C00-D49 Neoplasms
D3A-D3A Benign neuroendocrine tumors
D3A- Benign neuroendocrine tumors
2022 ICD-10-CM Diagnosis Code D3A.0

2022 ICD-10-CM Diagnosis Code D3A.0

Benign carcinoid tumors

2016

2017

2018

2019

2020

2021

2022

Non-Billable/Non-Specific Code

D3A.0 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
The 2022 edition of ICD-10-CM D3A.0 became effective on October 1, 2021.
This is the American ICD-10-CM version of D3A.0 - other international versions of ICD-10 D3A.0 may differ.

The following code(s) above D3A.0 contain annotation back-references

Annotation Back-References

In this context, annotation back-references refer to codes that contain:

Applicable To annotations, or
Code Also annotations, or
Code First annotations, or
Excludes1 annotations, or
Excludes2 annotations, or
Includes annotations, or
Note annotations, or
Use Additional annotations

that may be applicable to D3A.0:

C00-D49
2022 ICD-10-CM Range C00-D49
Neoplasms
Note
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
Neoplasms
D3A
ICD-10-CM Diagnosis Code D3A
Benign neuroendocrine tumors
Code Also
- any associated multiple endocrine neoplasia [MEN] syndromes (E31.2-)
Type 2 Excludes
- benign pancreatic islet cell tumors (D13.7)
Use Additional
- code to identify any associated endocrine syndrome, such as:
- carcinoid syndrome (E34.0)
Benign neuroendocrine tumors

Code History

2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
2017 (effective 10/1/2016): No change
2018 (effective 10/1/2017): No change
2019 (effective 10/1/2018): No change
2020 (effective 10/1/2019): No change
2021 (effective 10/1/2020): No change
2022 (effective 10/1/2021): No change

ICD-10-CM Codes Adjacent To D3A.0

D36.11 …… of face, head, and neck

D36.12 …… upper limb, including shoulder

D36.13 …… of lower limb, including hip

D36.14 …… of thorax

D36.15 …… of abdomen

D36.16 …… of pelvis

D36.17 …… of trunk, unspecified

D36.7 Benign neoplasm of other specified sites

D36.9 Benign neoplasm, unspecified site

D3A Benign neuroendocrine tumors

D3A.0 Benign carcinoid tumors

D3A.00 Benign carcinoid tumor of unspecified site

D3A.01 Benign carcinoid tumors of the small intestine

D3A.010 Benign carcinoid tumor of the duodenum

D3A.011 Benign carcinoid tumor of the jejunum

D3A.012 Benign carcinoid tumor of the ileum

D3A.019 Benign carcinoid tumor of the small intestine, unspecified portion

D3A.02 Benign carcinoid tumors of the appendix, large intestine, and rectum

D3A.020 Benign carcinoid tumor of the appendix

D3A.021 Benign carcinoid tumor of the cecum

D3A.022 Benign carcinoid tumor of the ascending colon

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

2022 ICD-10-CM Diagnosis Code D3A.0

Benign carcinoid tumors

Neoplasms

Benign neuroendocrine tumors